ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 44 filers reported holding ELOXX PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,000 | -25.0% | 19,280 | +48.1% | 0.00% | – |
Q2 2022 | $4,000 | +300.0% | 13,015 | +745.7% | 0.00% | – |
Q1 2022 | $1,000 | -85.7% | 1,539 | -84.0% | 0.00% | – |
Q4 2021 | $7,000 | -66.7% | 9,596 | -9.6% | 0.00% | -100.0% |
Q2 2021 | $21,000 | +90.9% | 10,612 | +222.6% | 0.00% | – |
Q1 2021 | $11,000 | -62.1% | 3,290 | -54.3% | 0.00% | -100.0% |
Q4 2020 | $29,000 | -62.8% | 7,193 | -75.7% | 0.00% | 0.0% |
Q3 2020 | $78,000 | +271.4% | 29,593 | +325.9% | 0.00% | 0.0% |
Q2 2020 | $21,000 | +425.0% | 6,949 | +229.3% | 0.00% | – |
Q1 2020 | $4,000 | -66.7% | 2,110 | +31.3% | 0.00% | -100.0% |
Q4 2019 | $12,000 | +100.0% | 1,607 | +19.4% | 0.00% | – |
Q3 2019 | $6,000 | -68.4% | 1,346 | -28.5% | 0.00% | -100.0% |
Q2 2019 | $19,000 | -80.0% | 1,882 | -76.8% | 0.00% | -83.3% |
Q1 2019 | $95,000 | +850.0% | 8,123 | +857.9% | 0.01% | +500.0% |
Q4 2018 | $10,000 | -93.2% | 848 | -90.1% | 0.00% | -87.5% |
Q2 2018 | $146,000 | – | 8,572 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 1,930,092 | $1,363,000 | 0.55% |
AMERICAN FINANCIAL GROUP INC | 1,480,000 | $1,045,000 | 0.29% |
Vanguard Capital Wealth Advisors | 158,900 | $111,000 | 0.08% |
Anson Funds Management LP | 553,652 | $391,000 | 0.04% |
Nantahala Capital Management | 894,659 | $632,000 | 0.02% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,094,208 | $1,479,000 | 0.02% |
Harel Insurance Investments & Financial Services Ltd. | 1,176,401 | $831,000 | 0.02% |
Atom Investors LP | 113,151 | $80,000 | 0.01% |
Virtu Financial LLC | 130,270 | $91,000 | 0.01% |
Altshuler Shaham Ltd | 1,157,540 | $828,000 | 0.01% |